دورية أكاديمية
أعرض في EDS

HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023).

التفاصيل البيبلوغرافية
العنوان: HIV drug resistance: analysis of viral genotypes and mutation loci in people living with HIV in Chongqing, China (2016-2023).
المؤلفون: Gao W; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China., Zhou G; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China., Li M; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China., Wang P; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China., Li J; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China., Deng R; Department of Medical Laboratory Medicine, Chongqing Public Health Medical Center, Chongqing, China. 2394250820@qq.com.
المصدر: AIDS research and therapy [AIDS Res Ther] 2024 Sep 13; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Sep 13.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405 (Electronic) Linking ISSN: 17426405 NLM ISO Abbreviation: AIDS Res Ther Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, 2004-
مواضيع طبية MeSH: HIV-1*/genetics , HIV-1*/drug effects , HIV Infections*/drug therapy , HIV Infections*/virology , HIV Infections*/epidemiology , Drug Resistance, Viral*/genetics , Genotype* , Mutation* , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/pharmacology, Humans ; China/epidemiology ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Young Adult ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/pharmacology ; Adolescent ; Aged
مستخلص: Background: Large-scale HIV genotype drug resistance study has not been conducted in Chongqing.
Methods: A retrospective study was conducted on people living with HIV(PLWH) who received HIV-1 genotype resistance testing at Chongqing Public Health Medical Center from May 2016 to June 2023. The HIV-1pol gene was amplified through RT-PCR and analyzed in terms of genotypic drug resistance.
Results: Of the 3015 PLWH tested for HIV-1 drug resistance, 1405 (46.6%) were resistant to at least one antiviral drug. Among non-nucleoside reverse transcriptase inhibitors (NNRTIs), 43.8% were resistant, compared to 29.5% for nucleoside reverse transcriptase inhibitors (NRTIs) and 3.4% for protease inhibitors (PIs). V179D/E and K103N/S were identified as the common mutation sites in the NNRTIs class of drugs, M184V/I and K65R/N were reported as the most common mutation sites in NRTIs, while thymidine analogue mutation (TAM) group was identified in 373 samples. L10FIV was the most common mutation in PIs. The dominant HIV-1 subtype was CRF07_BC.
Conclusions: The high prevalence of HIV-1 drug resistance in Chongqing underscores the imperative for rigorous surveillance of the local HIV epidemic. Furthermore, TAMs are associated with HIV-1 multidrug resistance, and timely detection of drug resistance is helpful to reduce the emergence and spread of such drug-resistant strains.
(© 2024. The Author(s).)
References: PLoS One. 2012;7(10):e47289. (PMID: 23056619)
Antimicrob Agents Chemother. 2020 Mar 24;64(4):. (PMID: 31988104)
Curr Opin Virol. 2012 Oct;2(5):636-43. (PMID: 23006584)
Lancet Infect Dis. 2017 Mar;17(3):296-304. (PMID: 27914856)
Epidemiol Infect. 2020 May 08;148:e102. (PMID: 32381145)
AIDS. 2010 May 15;24(8):1203-12. (PMID: 20395786)
J Res Med Sci. 2019 Apr 26;24:31. (PMID: 31143232)
Infect Dis Clin North Am. 2019 Sep;33(3):707-742. (PMID: 31255384)
J Clin Virol. 2004 Mar;29(3):152-9. (PMID: 14962783)
JAMA. 2023 Jan 3;329(1):63-84. (PMID: 36454551)
J Virus Erad. 2018 Nov 15;4(Suppl 2):55-58. (PMID: 30515315)
Sci Rep. 2016 Jan 14;6:19279. (PMID: 26763952)
J Antimicrob Chemother. 2012 Jun;67(6):1475-8. (PMID: 22371439)
J Antimicrob Chemother. 2019 Jan 1;74(1):172-176. (PMID: 30260417)
N Engl J Med. 2018 Mar 01;378(9):874. (PMID: 29504388)
PLoS One. 2020 Dec 21;15(12):e0243650. (PMID: 33347449)
HIV Med. 2022 Mar;23 Suppl 1:95-105. (PMID: 35293098)
معلومات مُعتمدة: 202316 Technology Innovation and Application Development Project of Chongqing Shapingba District; 202316 Technology Innovation and Application Development Project of Chongqing Shapingba District; 2020FYYX112 Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau; 2020FYYX112 Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau; 2020FYYX112 Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau; 2020FYYX112 Joint Medical Research Projects of Chongqing Municipal Health Committee and Chongqing Municipal Science and Technology Bureau
فهرسة مساهمة: Keywords: Drug resistance; Genotype; HIV-1; Thymidine analogue mutation
المشرفين على المادة: 0 (Anti-HIV Agents)
0 (Reverse Transcriptase Inhibitors)
تواريخ الأحداث: Date Created: 20240913 Date Completed: 20240914 Latest Revision: 20240916
رمز التحديث: 20240916
مُعرف محوري في PubMed: PMC11396324
DOI: 10.1186/s12981-024-00646-z
PMID: 39272106
قاعدة البيانات: MEDLINE
الوصف
تدمد:1742-6405
DOI:10.1186/s12981-024-00646-z